Rhenman & Partners Asset Management AB - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,366,000
-75.1%
159,924
-41.5%
0.16%
-71.6%
Q3 2018$5,477,000
-35.4%
273,593
-16.6%
0.55%
-36.8%
Q2 2018$8,477,000
+69.2%
328,193
+56.5%
0.87%
+40.5%
Q1 2018$5,010,000
-78.7%
209,644
-69.7%
0.62%
-80.5%
Q4 2017$23,483,000
+21.2%
692,913
-24.3%
3.17%
+28.3%
Q3 2017$19,371,000
+200.8%
915,000
+148.5%
2.47%
+167.4%
Q2 2017$6,439,000
+137.3%
368,166
+137.5%
0.92%
+115.1%
Q1 2017$2,713,000
+23.5%
155,000
+19.2%
0.43%
+2.1%
Q4 2016$2,197,000
-99.9%
130,0000.0%0.42%
+24.2%
Q3 2016$2,133,300,000
+108299.4%
130,0000.0%0.34%
-2.9%
Q2 2016$1,968,000130,0000.35%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders